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Sweet slumber: A case for melatonin as a sleep aid
Chapter 1: Introduction
This paper will present the process and groundwork of a university based sleep challenge
as well as a pertinent literature review for a focused research question. The Methodology section
outlines how the on campus research study was planned and conducted. The Results and
Discussion portion contains a narrative of research assistant duties performed for the study.
Lastly, the paper concludes with an Evaluation section discussing the learning experience and
application to clinical practice.
Background
Inadequate sleep is a rising problem in university students across the nation. Hershner
and Chervin (2014) report that as many as 70% of college students do not get adequate sleep and
50% report symptoms of daytime sleepiness. Inadequate sleep may not only be detrimental to a
student’s health, it can incur decreased academic and social performance, lower grade point
averages, and academic failure compared to students who receive sufficient sleep (Hershner &
Chervin (2014). The Center for Disease Control and Prevention (CDC) in 2014 called
inadequate sleep a public health epidemic, linking sleep deprivation to the cause of many
unwelcome motor vehicle accidents, workplace catastrophes, and medical errors (CDC, 2014).
While there is no specific pill that can cure sleep deprivation, only a significant lifestyle change
can promote healthy sleep hygiene and resulting sleep patterns.
The lack of sleep hygiene in college-aged populations led Southern Adventist
University’s (SAU) Graduate Nursing Department to conduct a sleep challenge on campus
during the month of February. Participants were expected to practice sleep hygiene by retiring
one to two hours prior to midnight and to arise at the same time each day. SAU also planned a
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spiritual component of devotional reading that would also be investigated as to its effectiveness
in enhancing sleep quality.
Research Question for Campus Study
The aim of this study was to investigate the impact of a two arm, 28-day and 14-day sleep
challenge combined with a nightly assigned Bible reading on sleep, stress, and personal faith
practice in the lives of college students attending a private university.
Statement of Purpose
For the purposes of this paper, the direct focus will be on the use of exogenous melatonin
on initiating sleep and sleep quality in healthy populations. Students participating in the Zoe 2.0
Sleep Challenge responded to a demographic form that inquired on the frequent use of sleep aids.
While the vast majority of the population studied did not use any sleep aids, melatonin was the
most frequently used at SAU. The question of melatonin’s effectiveness and usefulness in aiding
in sleep quality in the college age student should be investigated. The aim of this capstone paper
is to explore the effectiveness of exogenous melatonin in initiating sleep when compared with no
treatment or placebo in healthy populations of all ages.
Problem
Sleep deprivation and insomnia are not only an issue for college students, but they are
widespread issues that present problems nationwide. In the national 2013 Youth Risk Behavior
Survey, not even 8% of high school students were sleeping the recommended amount. Only a
third of high school students were reaching the minimal eight hours of sleep per night, and less
than 25% of seniors reporting the same. YRBS reports that a significant decrease in sleep is
linked to increased daytime sleepiness, sleeping in class, decreased focus, headaches, and poor
performance in school. In the same data analysis, researchers linked inadequate sleep with drug
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and alcohol use, increased sexual activity, suicide attempts, depression, and obesity (Youth Risk
Behavior Survey, 2015).
The National Sleep Foundation (2014) reported that 70 % of parents of children ages six
to eleven reported that their children need over nine hours of sleep and that on school nights the
children typically get at least one hour less than they should. In the same data analysis, parents
estimated their children’s sleep quality. They found that parents reported older children to have
poorer quality of sleep than younger children (National Sleep Foundation, 2014). In 2013, the
National Sleep Foundation did an international survey on sleeping habits in adults. They
discovered that Americans get the fewest amount of hours per night (less than six hours) on
weekdays/workdays when compared with other countries. Twenty one percent of those surveyed
reported getting less than six hours of sleep on workdays, another 32% reporting less than seven
hours, and another 25% tallying less than eight hours. Only 44% of Americans surveyed agreed
that they have a good night’s sleep almost every night, 25% of those surveyed report “rarely” or
“never” to the same question (National Sleep Foundation, 2013).
So the question remains why Americans of all ages are getting insufficient amounts of
sleep on a night-to-night basis. Some of the deficit can be attributed to chronic medical
conditions or mental health problems. But what about those in the population getting inadequate
sleep with no medical or mental problems? The CDC (2015) defines primary insomnia as an
inability to begin or sustain sleep. The problems can also present with middle of the night/early
morning rising with the inability to resume sleep. Insomnia can manifest symptoms of daytime
sleepiness and decreased functioning and performance during the day. As with any type of sleep
deprivation, insomnia also poses increased risks to others as a consequence of the lack of
adequate sleep (Center for Disease Control and Prevention (CDC), 2015).
Rational for PICO
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In light of conventional wisdom and present research on the topic of sleep deprivation
and insomnia in healthy populations, further exploration into alternative methods of achieving
better sleep is needed to help find a valuable solution to the widespread problem of sleep
deprivation and insomnia. Exogenous melatonin, an over the counter herbal supplement is an
alternative method for achieving better sleep worth investigating. As a result of this literature
review, this researcher is optimistic that a feasible solution to the problem of inadequate sleep
will be found with the use of exogenous melatonin. Questions of safety and effectiveness are also
points to ponder when considering this addition to sleep therapy.
Theoretical Framework
The theoretical framework chosen for this project is the CREATION Health model. The
CREATION Health model focuses on the wholistic care of the entire person and embodies the
topic of this project in one of the main pillars of the model. The model, CREATION, represents
Choice, Rest, Environment, Activity, Trust, Interpersonal Relationships, Outlook, and Nutrition.
This project focuses on the “R” or Rest section of the model and the importance of adequate
sleep and achieving optimal rejuvenating rest to regenerate the mind, body, and spirit
(CREATION Health, 2015).
Chapter 2: Literature Review
A widespread investigation of the current available literature was completed using
CINAHL and the following key terms: melatonin, sleep, quality, and insomnia. This resulted in
828 articles. The vast majority of the literature pertained to specific populations and was not
useful for this project; however, 23 articles were appropriate for the proposed research question.
Furthermore, many of the articles were not original studies and therefore not of particular use for
this project. The following is a review of the literature found on exogenous melatonin.
Pharmacological Profile of Exogenous Melatonin
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Lyseng-Williamson in 2012, released a drug profile on extended release melatonin.
Melatonin is a neurotransmitter, and the main regulator in regulating circadian rhythms. The
assets of melatonin that promote sleep are known to be in connection with its activity at
melatonergic receptors (MT1, MT2). MT1 is thought to play a role in inducing sleep when
melatonin is present, and MT2 assists the body in shifting from day and night circadian rhythms.
In her study, Lyseng-Williamson evaluated the effectiveness of Circadian PR 2mg, an exogenous
melatonin and recommended it for use in patients over the age of 55 with history of primary
insomnia. Benefits such as better sleep (p<0.05), increased daytime performance (p<0.05), and
no impairment of postural stability (p<0.01) were found to be in correlation with taking
melatonin. The only downside was possible “muzzy-headedness” if used in conjunction with
other sleep aids (Lyseng-Williamson, 2012).
Prolonged Release Melatonin Studies
In a different vein of research, two studies performed research on Melatonin prolonged
release (PR) Circadian 2mg given to patients with primary insomnia in different age groups. The
first study performed by Wade et al. (2010), was a double blind six-month study where patients
(n=746) between ages 18-80 (mean 63.8) were given either melatonin PR 2mg (Circadian) or
placebo. The study incorporated a single blind run in and run out to evaluate for rebound effects
and withdrawal symptoms. Patients were instructed to take medication at designated times and to
record sleep times and wakening in a sleep diary. Patients also completed subjective instruments
Pittsburg Sleep Quality Index (PSQI), World Health Organization -5 Wellbeing Index (WHO),
and Clinical Global Impression of Improvement (CGI). Patients were also tested prior to the start
of the study to determine if they were low excretors of melatonin. At the three-week mark, low
excretors were no different when compared with baseline (p =0.924). The 65-80 year old
experimental group was found to have significant results at the three-week mark when compared
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with placebo group (p=0.002). In the extended 26-week period, low excretors still remained
insignificant for sleep latency, quality and morning alertness when compared with baseline and
placebo (p=0.174, 0.266, 0.426 respectively). For the experimental 65-80 age group results
remained significant for sleep latency (p=0.002) with an average of falling asleep 15.6 minutes
earlier than placebo (Wade et al, 2010).
In a similar 2007 study by Lemoine, Talinir, Laudon, and Zisapel, researchers
investigated the effects of Circadian on quality of sleep and morning alertness in primary
insomnia patients (n=170) who were over the age of 55 (mean age 68.5). They performed a
comparable study that included single blind two-week washout periods at the beginning and end
of the experimental period and a double blind, randomized, controlled three-week treatment
period. The study used the Leeds Sleep Evaluation Questionnaire, and recorded sleep quality and
daytime quality in a sleep diary using Likert scales. The results were found to be significant
when comparing sleep quality in the treatment versus placebo groups (p=0.047), and when
compared with run in period baseline (p<0.0001). Morning alertness results also showed
significant results when compared with placebo and baseline (p=0.002, p=<0.0001) (Lemoine,
Talinir, Laudon, & Zisapel, 2007). The results amongst studies seemed to be in favor of
melatonin in the elder populations when endogenous melatonin levels are decreased. In both
studies however, melatonin was only effective against the placebo.
Melatonin in Children and Adolescents
The effects of melatonin in children and adolescents were studied differently than the
adult populations. In a small Swedish study, researchers investigated the effects of giving onemilligram melatonin in the afternoon on sleep induction, length of sleep, and daytime drowsiness
on adolescents with sleep induction insomnia. Eckerberg, Lowden, Nagai, and Akerstedt (2012)
performed a study on 23 teenagers (14-19) and were to keep sleep diaries and produce saliva

SWEET SLUMBER: A CASE FOR MELATONIN AS A SLEEP AID

8

samples intermittently for a 5-week study. Participants would be intermittently receiving placebo
or control predetermined by crossover groupings and would serve as their own control. Results
were between the placebo and experimental group were found to be statistically significant at
week one, two (p=0.05, 0.005). By the end of the fifth week 89% of participants reported
lengthier sleep times on school days than at week one (p=<0.05). Weekend sleep quality and
onset also was found to be significant when compared with placebo (p=0.05) In regards to side
effects, some students noted excessive tiredness when taking melatonin, others complained of
headache (Eckerberg, Lowden, Nagai, & Akerstedt, 2012).
In contrast, a study involving children with insomnia was conducted by Smits, Nagtegaal,
Heijden, Coenen, and Kerkhof, (2000). A five-week, double blind, randomized controlled study
was done on children ages 6-12 (n=40) diagnosed with primary insomnia for more than one year.
Children enrolled in the study were to take either 5mg melatonin or placebo pill. The study
consisted of a one-week baseline period followed by a four-week experimental trial. After the
four-week experimental period, melatonin levels (saliva), sleep latency and length, and attention
performance were assessed. Total sleep time was considered significant (p=0.035) between
placebo and intervention groups. Melatonin levels via saliva samples correlated with sleep
diaries provided by parents of participants (p=0.016) and actigraphic data (p=0.033). Results for
attention to performance were not found to be significant for either group (p>0.05). Side effects
reported by parents included: two of the participants complaining of headache, one developed
mild epilepsy, and many of the children developed excessive sleepiness (Smits, Nagtegaal,
Heijden, Coenen, & Kerkhof, 2000).
Primary Insomnia and Melatonin
Two studies were performed involving patients with a diagnosis of primary
insomnia. A double blind, controlled 60-day study in Italy in 2011, was conducted on patients
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with primary insomnia in a long-term care residence. This study used a combination of
medications infused in a pear pulp that included melatonin 5 mg, 11.25 mg of zinc, and 225mg
of magnesium. Participants were otherwise healthy and screened for other causes of insomnia
prior to induction of the study. The researchers aimed to determine if their concoction would
have a positive effect on sleep quality in the long-term care facility. Subjects (n=43) were given
either a placebo of pear pulp or the mixture of supplement and melatonin (5mg) for 60 days.
Patients answered subjectively to many instruments; however, the PSQI was most reliable. The
researchers discovered a difference between the placebo and the treatment groups (p<0.001) and
a significant change from baseline in the treatment group (p<0.001) Many of their secondary
outcomes were also worth mentioning, all significant: increased morning alertness and activity
(p=0.001), increased mood scores on the Geriatric Depression Scale (p=0.002), and increase in
total sleep time (p=0.001) (Rondanelli, Opizzi, Monteferrario, Antoniello, Manni, & Klersy,
2011).
In a contrasting study, Montes, Uribe, Sotres, and Martin (2003) conducted a double
blind controlled crossover study using melatonin as a treatment for primary insomnia. They used
melatonin 0.3mg or 1mg as the intervention and a standard placebo for the control group.
Participants (n=10, mean age 50) were to take medication one hour before bedtime and sleep was
then recorded via polysomnography. Each participant would eventually take all three treatments
(placebo, 0.3mg, 1 mg melatonin) for a week followed by a five-day washout phase, with each
serving as their own control in the crossover design. Subjects submitted subjective evaluations
on sleep quality each morning and EEG recordings were reviewed before data analysis. The
researchers found that there was no significant difference between groups or placebo for sleep
quality (p=0.33), latency (p=0.11) or length of sleep (p=0.83).
Melatonin in Healthy Adults
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In a study testing health adults without insomnia, both melatonin 6mg, and the
expectation of receiving melatonin was investigated as to its effects on sleep quality and feelings
upon awakening. Rose & Kahan, 2001, performed a small eight-day study for healthy adults
aged 26-71 (n=53). Patients who participated were involved in a 2x2 study (expected treatment x
actual treatment) crossover design. All patients would receive two days of expecting melatonin
and receiving melatonin, two days of expecting treatment but receiving placebo, two days of
expecting placebo and receiving melatonin, and two days of expecting placebo and receiving
placebo. On average, patient’s ratings of sleepiness were greater if they received melatonin
(p=0.01), however, ratings were not significantly different from those who expected to receive
melatonin but received placebo (p=0.32). In regards to continuous sleep, participants rated sleep
better when they expected melatonin, regardless of whether they received placebo or melatonin
(p=0.02). Overall, the expectation of melatonin regardless if the participant received it or not
produced significant results (Rose & Kahan, 2001).
In an isolated study, Wyatt, Dijk, De Cecco, Ronda, & Czeisler in 2006, performed a
controlled sleep study on healthy adults (ages 18-30) in a sleep center with the omission on
time/space inquiry. Participants were given exogenous melatonin of either 0.3mg or 5 mg dose or
placebo pill half an hour prior to scheduled six-hour sleep sessions. Participants’ sleep was
measured by polysomnography sensors throughout the study. Participants were exposed to light
and dark situations at scheduled times both on and off natural circadian rhythms. The difference
of sleep latency between melatonin and placebo groups was not found to be significant (p=0.25).
There were also no significant differences found between sleep latency and consolidated sleep
between melatonin and placebo group (p>0.05). The only comparison that results were found to
be significant was when melatonin was given during the circadian day and endogenous
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melatonin was not already present (Wyatt, Dijk, De Cecco, Ronda, & Czeisler (2006). Neither of
the two above studies showed significance for the use of melatonin in healthy adult populations.
A small 35-day study involving 12 subjects (aged 20-45) studied melatonin’s effects on
circadian rhythms was conducted by Crowley and Eastman in 2012. Participants in this study
shifted sleep schedules an hour forward nightly from previous night while following a sleep
schedule set by the researchers. Participants were instructed to take either melatonin or placebo
11 hours prior to midpoint in sleep session. Endogenous levels of melatonin were also measured
via saliva samples. Participants also took tests via mobile devices to assess sustained attention
and focus. The researchers found that there was no significant difference in sleep length for
baseline and experimental groups or placebo. They did conclude that the addition of exogenous
melatonin and gradually earlier bedtimes did shift the dim light melatonin onset by 38 minutes
sooner than participants only taking placebo. A downside however, showed that participants
were more tired and drowsy upon awakening on days when melatonin was taken the previous
night when compare with the baseline data (p<0.05). The 3mg dose of melatonin showed a
faintly better circadian shift than the placebo drug. The researchers of the study did not
recommend the use of melatonin alone to shift circadian clock (Crowley & Eastman, 2012).
Chapter 3: Methodology
Research Design
The research design for the Zoe 2.0 Sleep Challenge was a two-arm quasi-experimental
control group design with 28-day and 14-day experimental and control groups. The 28-day arm
began the first day of February; the 14-day arm started 14 days later so that both arms concluded
at the same time. Both arms of the study had intervention and control groups. The experimental
groups focused on two interventions: 1) make a valiant effort for bedtime one to two hours
before midnight, and 2) read a short devotion nightly provided by researchers before bedtime.
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Throughout the study, participants were asked to get a minimum of eight hours of sleep per
night, including weekends and to retire at least one to two hours before midnight each night.
Participants were also encouraged to rise at the same time each morning to develop consistency
and routine.
In addition to the pre and post data tools utilized for all participants (see “Measurements”
below), the study collected daily sleep logs via an online survey tool for the two intervention
groups. The surveys were intended to keep track of bedtime, wakeup time, devotion compliance,
and subject’s perception of sleep quality the night before.
Population/Sample
The sample for this sleep challenge was derived from students at Southern Adventist
University. Students were given the choice to volunteer for either the control group or the
challenge group. Recruitment for the study consisted of flyers, publications in school newspaper,
and in class presentations from members of the research team. Students with personal medical
history of sleep apnea, narcolepsy, or who are currently on prescription sleep aids were excluded
from the study.
Ethical Considerations
The Zoe 2.0 Sleep Study did not pose any particular risk to participants; however, each
participant was required to sign an informed consent form that illustrated potential risks and
confidentiality matters. An IRB was submitted to the University’s ethics committee for review
prior to beginning of research study.
Procedures
Participants were recruited in a variety of ways throughout campus. Some students
inquired about the study after seeing postings around campus. The research assistants enrolled
the majority of students in the Zoe 2.0 Study through in-class presentations. Participants were
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asked to complete a demographic form, Pittsburg Sleep Quality Index (PSQI), Perceived Stress
Scale (PSS-14), and Daily Spiritual Experience Scale (DSES) as a part of baseline data and an
informed consent upon enrolling in the study and at the conclusion of the study. Daily fourquestion surveys were sent out via email through QuestionPro, a survey response system for the
course of the study to obtain daily feedback from participants. If participants did not respond to
daily survey by noon, a reminder emails with links to outstanding surveys were sent to the
delinquent participants.
Variables
The independent variable(s) in this research study were the components of the sleep
challenge that participants agreed upon when entering the study. The subjects strived to get to
sleep at least one to two hours before midnight and read the nightly devotional before retiring for
the evening. The dependent variable for the study was effect the intervention has on the
participant’s quality of sleep, perceived stress, and spiritual wellbeing.
Measurements
The data collected consisted of four measurements as well as a demographic
questionnaire at the start of the study. Three instruments were completed both at the start and
completion of the study, the last was a daily survey sent out throughout the course of the sleep
challenge.
The first instrument used for the study was the Pittsburgh Sleep Quality Index (PSQI)
that was used to subjectively measure the quality of sleep and any particular patterns in sleep
habits. The PSQI has an internal consistency reliability rating of .83 computed by Cronbach’s
Alpha. The instrument measured on a Likert scale ranging from poor to good and tested seven
areas related to sleep. The Likert score ranged from 0 to 3 for each individual question and the
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addition of all 7 questions gives a global score, which is then rated to determine overall sleep
health (Buysse, Reynolds III, Monk, Berman, & Kupfer, 1989).
A 16-item instrument assessing everyday experiences in correlation with spiritual life
was utilized for the spiritual component of the study. The Daily Spiritual Experience Scale
(DSES) measured concepts ranging from feelings of inner peace to diving connection with a
higher power. The Cronbach’s alpha of internal reliability consistency is reported as .95
(Underwood, & Teresi, 2002).
The Perceived Stress Scale (PSS-14) is a 14-question instrument devised to gauge the
level of stress an individual perceives in their lives. The participants specify to which degree they
have found themselves feeling out of control, erratic, and encumbered in the last 30 days. The
internal consistency validity of the instrument was measured via Cronbach’s alpha and tested
between .60 and .91. Test-retest reliability of the PSS-14 instrument was >.70 computed via
correlation coefficient (Lee, 2013).
The daily survey consisted of four questions pertaining to the subject’s sleep habits the
night before (see Appendix B). In the survey, the participants were asked to rate their quality of
sleep on a zero to ten Likert scale, indicate the actual times of sleep and awakening, and answer
honestly if they successfully read the nightly devotion. The researchers of the Zoe 2.0 Sleep
Challenge formulated the brief survey and a test of validity and reliability was not performed.
The purpose of the survey was to collect day-to-day data and provide graphical trends that may
help explain pre and post instrument results.
Data Analysis
The current plan for data analysis will include an independent t-test to identify alterations
between the control group and experimental group for both the 28-day and 14-day arms.
Independent t-tests will also be performed to determine changes within the groups from pre and
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post sleep challenge data. A multiple regression analysis is also planned to determine
correlations between demographic factors such as age, gender, housing situation, caffeine intake,
exercise, and alternative therapies used for sleep and sleep quality.
Chapter 4: Results & Discussion
Research Findings
At this time, the data has been cleaned and the initial preliminary tests are being
performed on the data. Initially, 10.2% of participants reported they used melatonin for sleep on
a regular basis while 86% reported no medication use. Lesser used Valerian and Benadryl
constituted 1.2% for each. The research team is still in the process of conducting preliminary
independent t-tests to determine pre and post differences and differences between the placebo
and intervention groups.
Research Assistant Duties
Participant Recruitment. As a research assistant, I assisted at the main information
meeting for the Zoe 2.0 Sleep Challenge. A brief information meeting was conducted and
informed consents and contact information were obtained from participants.
Research Design. During the planning phase of the Zoe 2.0 project, I was involved in the
formation of a demographic form (see Appendix A) that would help the researchers grasp a
sense of the overall population being studied. The demographic form also served the purpose of
enlightening the researchers as to the many variables that may affect the subject’s sleep patterns;
for example, caffeine intake, light/noise exposure, current medications, and current medical
conditions. This data was collected at the beginning of the study when participants enrolled and
signed consent forms.
Data Collection. Data collection is where I spent the majority of my time as a research
assistant. As a part of the data collection duties, I fostered the implementation and collection of
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the daily surveys. Participants were instructed to submit a brief four-question survey every
morning upon awakening. My job was to dispatch the e-mail link to the survey every morning
and reminder e-mails throughout the day to participants who had not yet submitted their answers.
The Zoe 2.0 study utilized QuestionPro, a survey response system, to obtain survey results from
participants. These results were automatically transferred into Excel files where the participants’
QuestionPro generated identification numbers were converted to the assigned ID numbers given
by the Zoe 2.0 study.
Data Entry. The main tasks for my portion of data entry was to accurately and manually
enter all the data from the demographic form into SPSS version 21. This was done by creating
an SPSS file with all the components of the demographic form integrated into an arrangement
that can be easily analyzed by the program. Two researchers entered each demographic form into
separate SPSS files to verify accuracy and consistency.
Data Cleaning. After the initial input of data into the SPSS file, the data was tested by
another research assistant who then determined if there were any discrepancies found in the
demographic data submitted. Even after multiple entries and edits from both researchers, some
data still was not a consistent match and is still being checked against the participant responses
on the demographic forms.
Chapter 5: Evaluation
Learning and Experience
Overall, I feel privileged to have had the opportunity to be involved in this research
study. The ability to be engaged first hand in the throws of constructing, initiating and
implementing the study has given me a front seat learning experience of all the details and time it
takes to conduct research on even just a small scale. I learned that research is harder than it
looks, and that the planning process is often more important than the actual study. A successful
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study needs relentless scrutiny in the planning stages in order to illuminate all the potential
pitfalls and unforeseen circumstances of the study. This experience has given me a new
appreciation for the professional researchers who are relentlessly working to give the health
community the latest and most evidence based practice recommendations.
Application to nursing practice
Based off the investigation into the use of melatonin as a sleep aid, the only population I
can see myself prescribing melatonin is to the patient over the age of 65. Due to its safety profile
and short half -life, I have found no reservation to prescribing this course of treatment.
The use of melatonin in younger populations and children presented mixed results and
not enough consistent data to validate the use in practice. Further research of the use of
melatonin is still needed in all areas.
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Appendix A
Southern Adventist University

Participant ID #___________

DEMOGRAPHIC QUESTIONNAIRE
1.What is your current age? ______ years
2.What is your gender?
a. Male
b. Female
3. What is your current relationship status?
a. Single
b. Married
c. Widowed
d. Divorced
4.What is your current height? _______ft. ________ in.
5.What is your current weight? __________lb.
6.What is your ethnicity?
a. Caucasian
b. African American
c. Asian
d. Native American
e. Hispanic
f. Pacific Islander
g. Other: _________________________________
7.Where do you live currently?
a. Dorm room
b. Off campus housing or apartment
c. At home with parents
d. Southern Village
8. What is your academic year?
a. Freshman
b. Sophomore
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c. Junior
d. Senior
e. Graduate level
9. What is your current area of study (major)? ______________________________
10.On average, how many minutes per week do you engage in vigorous physical activity (e.g.
running, hiking, soccer, basketball)? _____________________
11.On average, how many minutes per week do you engage in moderate physical activity (e.g.,
walking)? _____________________
12. How many days per week do you eat after 7:00 PM? ___________________
13.On average, how many ounces of water do you drink per day? _______________
14.How many caffeinated beverages do you typically drink per day? _____________
15.What types of caffeine do you typically consume?
a. Coffee
b. Soda
c. Monster/ Red Bull
d.5 hour energy
e. Spark
f. Other: ______________________________________
16. Do you use any form of nicotine?
a. No
b. Cigarettes
c. Vapors
d. Chewing tobacco
e. Other:____________________________
17. At what hour do you typically go to bed? _____________________
18.How do you currently rank the noise in your sleeping environment?
a. 0 (no noise)
b. 1 (light noise)
c. 2 (moderate noise)
d. 3 (disturbing noise)
e. 4 (extremely disturbing noise)
19. How do you currently rank the light/brightness in your sleeping environment?
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a. 0 (completely dark/black)
b. 1 (minimal light)
c. 2 (some light)
d. 3 (moderate light)
e. 4 (completely light)
20. Do you currently have problems sleeping due to pain?
a. No
b. Yes, (please rate your pain while trying to fall asleep on a 0-10 scale with 0 being no pain and
10 being the worst imaginable pain) _______________
21. What medications, if any do you take for sleep? (Select all that apply)
a. No medication
b. No natural herbal products
c. Melatonin
d. Hops
e. Ambien
f. Lunesta
g. Benadryl
h. Tylenol PM
i. Zzz Quil
j. Alcoholic beverages
k. Valerian
l. Kava Kava
m. L-Tryptophan
n. L-Theanine
o. Chamomile
p. Other (please list):____________________________________________________
22. Have you tried any of the following alternative therapies?
a. Acupuncture
b. Alpha – stimulation
c. Warm baths before bed
d. Aromatherapy
e. White noise
f. Other (please list):____________________________________________________
23. Do you have a history of any of the following disorders/conditions in the last year? (Select all
that apply)
a. Panic Disorder
b. Anxiety
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c. Depression
d. Sleep Apnea
e. Insomnia
f. Hypo/Hyperthyroidism
g. Food sensitivities
h. Acid reflux (GERD)
24. Are you taking medications for blood pressure?
a. No
b. Yes, (please list) __________________________________________________
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Appendix B
Zoe 2.0 Daily Sleep Survey
1. What time did you go to sleep last night? (Please enter in hour format 00:00) ____
2. What time did you wake up this morning? (Please enter in hour format 00:00) ____
3. On a zero to ten Likert scale, how would you rate your sleep last night? _____
4. Did you read you devotional last night?
a. Yes
b. No
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